Cardiovascular Events and COX-2 Inhibitors
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2001-12, Vol.286 (22), p.2808-2813 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2813 |
|---|---|
| container_issue | 22 |
| container_start_page | 2808 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 286 |
| creator | Burnakis, Thomas G |
| description | |
| doi_str_mv | 10.1001/jama.286.22.2808 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_211393203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>1031621</ama_id><sourcerecordid>147769361</sourcerecordid><originalsourceid>FETCH-LOGICAL-a482t-796044b5b4f2a2ab954cd78dd9a32c0255e16d217d97bc9309bd0427829a0ff23</originalsourceid><addsrcrecordid>eNqF0EFLwzAUwPEgipvTu3iQ4lHofHlJmuQoZepgsIuCt5I0LXZs7UxawW9vYRNvMZd3-P1JeCHkmsKcAtCHjdmZOapsjjgOUCdkSgVTKRNanZIpgFap5IpPyEUIGxgPZfKcTCiVTEhOp-Q-N9413ZcJ5bA1Pll8VW0fEtO6JF-_p5gs24_GNn3nwyU5q802VFfHOSNvT4vX_CVdrZ-X-eMqNVxhn0qdAedWWF6jQWO14KWTyjltGJaAQlQ0c0il09KWmoG2DjhKhdpAXSObkbvDvXvffQ5V6ItNN_h2fLJASplmCOy_SGRK8jG6PUaD3VWu2PtmZ_x38bv-GNwcgvEf_xQYzVDHUMYwi6GIIY8hiyHGMLonRJBq9gOrJavH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211356874</pqid></control><display><type>article</type><title>Cardiovascular Events and COX-2 Inhibitors</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Burnakis, Thomas G</creator><creatorcontrib>Burnakis, Thomas G</creatorcontrib><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.286.22.2808</identifier><identifier>PMID: 11735741</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Cardiovascular Diseases - epidemiology ; Cyclooxygenase 2 ; Cyclooxygenase 2 Inhibitors ; Cyclooxygenase Inhibitors - adverse effects ; Cyclooxygenase Inhibitors - pharmacology ; Heart - drug effects ; Humans ; Isoenzymes - antagonists & inhibitors ; Membrane Proteins ; Prostaglandin-Endoperoxide Synthases ; Risk Factors</subject><ispartof>JAMA : the journal of the American Medical Association, 2001-12, Vol.286 (22), p.2808-2813</ispartof><rights>Copyright National Library of Medicine - MEDLINE Abstracts Dec 12 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.286.22.2808$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.286.22.2808$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3340,27924,27925,76489,76492</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11735741$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burnakis, Thomas G</creatorcontrib><title>Cardiovascular Events and COX-2 Inhibitors</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><subject>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Cardiovascular Diseases - epidemiology</subject><subject>Cyclooxygenase 2</subject><subject>Cyclooxygenase 2 Inhibitors</subject><subject>Cyclooxygenase Inhibitors - adverse effects</subject><subject>Cyclooxygenase Inhibitors - pharmacology</subject><subject>Heart - drug effects</subject><subject>Humans</subject><subject>Isoenzymes - antagonists & inhibitors</subject><subject>Membrane Proteins</subject><subject>Prostaglandin-Endoperoxide Synthases</subject><subject>Risk Factors</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0EFLwzAUwPEgipvTu3iQ4lHofHlJmuQoZepgsIuCt5I0LXZs7UxawW9vYRNvMZd3-P1JeCHkmsKcAtCHjdmZOapsjjgOUCdkSgVTKRNanZIpgFap5IpPyEUIGxgPZfKcTCiVTEhOp-Q-N9413ZcJ5bA1Pll8VW0fEtO6JF-_p5gs24_GNn3nwyU5q802VFfHOSNvT4vX_CVdrZ-X-eMqNVxhn0qdAedWWF6jQWO14KWTyjltGJaAQlQ0c0il09KWmoG2DjhKhdpAXSObkbvDvXvffQ5V6ItNN_h2fLJASplmCOy_SGRK8jG6PUaD3VWu2PtmZ_x38bv-GNwcgvEf_xQYzVDHUMYwi6GIIY8hiyHGMLonRJBq9gOrJavH</recordid><startdate>20011212</startdate><enddate>20011212</enddate><creator>Burnakis, Thomas G</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20011212</creationdate><title>Cardiovascular Events and COX-2 Inhibitors</title><author>Burnakis, Thomas G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a482t-796044b5b4f2a2ab954cd78dd9a32c0255e16d217d97bc9309bd0427829a0ff23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - adverse effects</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Cardiovascular Diseases - epidemiology</topic><topic>Cyclooxygenase 2</topic><topic>Cyclooxygenase 2 Inhibitors</topic><topic>Cyclooxygenase Inhibitors - adverse effects</topic><topic>Cyclooxygenase Inhibitors - pharmacology</topic><topic>Heart - drug effects</topic><topic>Humans</topic><topic>Isoenzymes - antagonists & inhibitors</topic><topic>Membrane Proteins</topic><topic>Prostaglandin-Endoperoxide Synthases</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burnakis, Thomas G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burnakis, Thomas G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular Events and COX-2 Inhibitors</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2001-12-12</date><risdate>2001</risdate><volume>286</volume><issue>22</issue><spage>2808</spage><epage>2813</epage><pages>2808-2813</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><cop>United States</cop><pub>American Medical Association</pub><pmid>11735741</pmid><doi>10.1001/jama.286.22.2808</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2001-12, Vol.286 (22), p.2808-2813 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_journals_211393203 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - pharmacology Cardiovascular Diseases - epidemiology Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Cyclooxygenase Inhibitors - adverse effects Cyclooxygenase Inhibitors - pharmacology Heart - drug effects Humans Isoenzymes - antagonists & inhibitors Membrane Proteins Prostaglandin-Endoperoxide Synthases Risk Factors |
| title | Cardiovascular Events and COX-2 Inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A59%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20Events%20and%20COX-2%20Inhibitors&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Burnakis,%20Thomas%20G&rft.date=2001-12-12&rft.volume=286&rft.issue=22&rft.spage=2808&rft.epage=2813&rft.pages=2808-2813&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.286.22.2808&rft_dat=%3Cproquest_pubme%3E147769361%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211356874&rft_id=info:pmid/11735741&rft_ama_id=1031621&rfr_iscdi=true |